None listed
Conditions
Brief summary
iTestis is a detailed database that will allow the collection of high quality clinical data in patients with Germ Cell Tumour. Who is it for? You may be eligible for this study if you have confirmed germ-cell tumor arising primarily in the testes, retro-peritoneum or mediastinum. Study details All enrolled patients will contribute data to the development of the web database. Data captured will include presentation and disease characteristics, patient characteristics, local and systemic therapies, surveillance methods, recurrence data and treatment outcomes. Data will be collected for up to 4 years and will be updated regularly by study personnel throughout the patient’s treatment and follow-up from their medical record. It is hoped this study will will help to describe the current care and treatment patterns for GCT patients and identify any deficiencies or abnormalities to ensure that Australian GCT patients receive the best care possible.
Interventions
The follow-up period is 4 years. No additional tests are required, all data will be collected from the medical record of patients with histologically or cytologically confirmed Germ Cell Tumour. Data captured will include presentation and disease characteristics, patient characteristics, local and systemic therapies, surveillance methods, recurrence data and treatment outcomes.
Sponsors
Walter and Eliza Hall Institute for Medical Research
Eligibility
Sex/Gender
Male
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
Histologically or cytologically confirmed GCT (non-seminoma or seminoma); or exceptionally raised tumour markers (AFP greater then or equal to 1000ng/mL and/or HCG greater than or equal to 5000 IU/L) without histological or cytological confirmation in the rare case where biopsy may not be feasible. Primary arising in testis, retro-peritoneum, or mediastinum.
Exclusion criteria
None
Outcome results
None listed